tiprankstipranks
Trending News
More News >
Keros Therapeutics, Inc. (KROS)
NASDAQ:KROS
US Market

Keros Therapeutics (KROS) Ownership - Who Owns Keros Therapeutics?

Compare
362 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 20, 2026
xxxxxxxxxxxxx
$113433
Feb 20, 2026
xxxxxxxxxxxxx
$77483
Feb 20, 2026
xxxxxxxxxxxxx
$63324
Oct 17, 2025
xxxxxxxxxxxxx
$84975125

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2025
xxxxxxxxxxxxx
$305400
Dec 31, 2025
xxxxxxxxxxxxx
$855120

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,637,319Insider15.22%76,886,749
4,637,319Insider15.22%76,886,749
2,189,882Institution7.19%36,308,244
1,475,417Institution4.84%24,462,414
1,252,397Institution4.11%20,764,742
1,059,305Institution3.48%17,563,277
708,255Institution2.32%11,742,868
609,507Institution2.00%10,105,626
480,615Institution1.58%7,968,597
454,005Institution1.49%7,527,403

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,475,417Institution4.84%24,462,414
480,615Institution1.58%7,968,597
454,005Institution1.49%7,527,403
381,741Institution1.25%6,329,266
341,083Institution1.12%5,655,156
273,719Institution0.90%4,538,261
170,323Institution0.56%2,823,955
160,357Institution0.53%2,658,719
135,004Institution0.44%2,238,366
119,253Institution0.39%1,977,215

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
716,926Institution2.35%11,886,633
595,316Institution1.95%10,662,110
554,263Institution1.82%9,206,308
253,656Institution0.83%4,205,616
214,198Institution0.70%3,836,286
209,880Institution0.69%3,479,810
170,640Institution0.56%2,834,330
170,640Institution0.56%2,834,330
170,640Institution0.56%2,834,330
139,094Institution0.46%2,491,174

FAQ

Who Owns Keros Therapeutics, Inc. (KROS)?
Currently, no data Available
What percentage of Keros Therapeutics, Inc. (KROS) stock is held by institutional investors?
Currently, no data Available
What percentage of Keros Therapeutics, Inc. (KROS) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Keros Therapeutics, Inc. (KROS)?
Tomer Kariv owns the most shares of Keros Therapeutics, Inc. (KROS).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.